<!DOCTYPE html><html prefix="og: http://ogp.me/ns#" lang="zh">
<!-- Mirrored from cn.nytimes.com/business/20130101/c01genomics/zh-hant/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:18:45 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head><meta charset="UTF-8"><!-- Browser render  --><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta name="renderer" content="webkit"><!-- End Browser render --><meta name="keywords" content=""><meta name="description" content="深圳華大基因對加州完整基因的收購案充滿爭議，一些科學家、政界人士和業界高管稱，這將威脅美國在DNA測序領域的競爭力。"><meta id="uuid" name="uuid" content="0e48be26781a30ca06d8fc500eccb769"><meta id="headline" name="headline" content="美國批准中方收購DNA測序公司 - 紐約時報中文網"><meta id="byline" name="byline" content="ANDREW POLLACK"><meta id="date" name="date" content="2013-01-01T09:17:48.000Z"><link rel="alternate" href="../../index.html" hreflang="zh-Hans"><link rel="alternate" href="../index.html" hreflang="zh-Hant"><link rel="canonical" href="../index.html"><link rel="alternate" type="application/rss+xml" href="https://cn.nytimes.com/rss/zh-hant/"><meta name="apple-itunes-app" content="app-id=807498298, app-argument=nytimescn://article:0e48be26781a30ca06d8fc500eccb769"><meta name="lang" property="lang" content="zh-cmn-hant"><!-- Apple IOS safari private meta --><link rel="apple-touch-icon-precomposed" sizes="144×144" href="../../../../../../static01.nyt.com/images/icons/ios-ipad-144x144.png"><link rel="apple-touch-icon-precomposed" sizes="114×114" href="../../../../../../static01.nyt.com/images/icons/ios-iphone-114x144.png"><link rel="apple-touch-icon-precomposed" href="../../../../../../static01.nyt.com/images/icons/ios-default-homescreen-57x57.png"><meta name="apple-mobile-web-app-title" content="美國批准中方收購DNA測序公司 - 紐約時報中文網"><meta name="apple-mobile-web-app-capable" content="yes"><!-- End Apple IOS safari private meta --><!-- Viewport and mobile --><meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no,maximum-scale=1,minimum-scale=1,minimal-ui"><!-- End viewport and mobile --><meta http-equiv="Cache-Control" content="no-siteapp"><meta name="format-detection" content="telephone=no"><meta name="HandheldFriendly" content="true"><meta name="MobileOptimized" content="320"><meta name="x5-orientation" content="portrait"><meta name="full-screen" content="yes"><meta name="x5-fullscreen" content="true"><meta name="browsermode" content="application"><meta name="x5-page-mode" content="app"><meta name="msapplication-tap-highlight" content="no"><meta property="og:title" content="美國批准中方收購DNA測序公司"><meta property="og:type" content="article"><meta property="og:url" content="../index.html"><meta property="og:description" content="深圳華大基因對加州完整基因的收購案充滿爭議，一些科學家、政界人士和業界高管稱，這將威脅美國在DNA測序領域的競爭力。"><meta property="og:site_name" content="紐約時報中文網"><meta property="article:publisher" content="https://www.facebook.com/nytimeschinese"><meta property="article:published_time" content="2013-01-01T09:17:48.000Z"><meta property="fb:pages" content="1504603339831430"><meta property="fb:app_id" content="853699254762608"><meta property="og:image" content="../../../../../../static01.nyt.com/images/2012/12/31/business/jpGENOMICS/jpGENOMICS-articleLarge.html"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:url" content="../index.html"><meta property="twitter:title" content="美國批准中方收購DNA測序公司"><meta property="twitter:description" content="深圳華大基因對加州完整基因的收購案充滿爭議，一些科學家、政界人士和業界高管稱，這將威脅美國在DNA測序領域的競爭力。"><meta property="twitter:domain" content="cn.nytimes.com"><meta property="twitter:site" content="@nytchinese"><meta property="twitter:creator" content="@nytchinese"><meta property="twitter:image:src" content="../../../../../../static01.nyt.com/images/2012/12/31/business/jpGENOMICS/jpGENOMICS-articleLarge.html"><meta name="PT" content="article"><meta name="PST" content="News"><meta name="CG" content="business"><meta name="SCG" content=""><meta name="sourceApp" content="nyt-china-web"><meta name="ptime" content="20130101021755"><meta name="utime" content="20130101091748"><meta name="pdate" content="20130101"><meta name="dat" content="Jan. 01, 2013"><meta name="hdl" content="美國批准中方收購DNA測序公司"><meta name="byl" content="ANDREW POLLACK"><meta name="lp" content="深圳華大基因對加州完整基因的收購案充滿爭議，一些科學家、政界人士和業界高管稱，這將威脅美國在DNA測序領域的競爭力。"><link rel="shortcut icon" href="https://static01.nyt.com/favicon.ico"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/style-flex.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/web/style.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/article.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/slideshow/slideshow.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/cookie-banner/style.min619b.css?v=f1810d8"><title>美國批准中方收購DNA測序公司 - 紐約時報中文網</title></head><script>var js_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/js";
 var imgs_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style/imgs";
 var style_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style";
 var site = 1;
 var sectionName = "business";
 var adTyp = "art";
 var cookieString = {
     "title": "您的追蹤器設置",
     "headline": "我們使用 cookie 做什麼？",
     "summary": '<p>我們利用cookies和類似的技術識別您的重複訪問和偏好。我們還使用它們來衡量廣告系列的效果，定位廣告並分析和網站流量。更多關於cookies的資訊（包括如何停用），<a href="https://www.nytimes.com/zh-hant/privacy/cookie-policy" rel="noreferrer noopener" target="_blank" data-testid="GDPR-policy">請查看我們的「Cookie政策」</a>。</span><span>自2020年7月20日起，我們將根據您在我們服務中所訪問的內容類型向您顯示我們認為與您的興趣相關的廣告。您可以<a href="https://www.nytimes.com/zh-hant/privacy/cookie-policy#how-do-i-manage-trackers" rel="noreferrer noopener" target="_blank" data-testid="GDPR-objection">提出反對</a>。希望了解更多信息，請參見我們的<a href="https://nytimes.com/zh-hant/privacy/privacy-policy#we-allow-for-personalized-advertising-on-times-services" rel="noreferrer noopener" target="_blank" data-testid="GDPR-privacy">隱私政策</a>。</p><p>透過在此處點擊「我接受」或者「X」， 您將被視為同意使用cookies。您隨時可以通過我們的Cookie政策來更改您的跟踪器偏好。</p>',
     "button": "接受",
     "trackerButton": "您的追蹤器設置",
     "rejectButton": "拒絕所有",
     "lang": 'zh-hant',
     "trackerLink": "https://www.nytimes.com/zh-hant/privacy/cookie-policy",
 };
 var purrString = {
     "button": "請勿出售我的個人資訊",
     "snackbar": "你的設定已經保存在此瀏覽器和設備上。如果你清除了 cookie，這些設定也會被清除。",
     "snackbarError": "Something went wrong",
     "optedOutText": "我们不再出售您的個人資訊",
     "CFALinkText": "California Notices",
     "purrPopupTitle": "Your request to not sell your data will be stored for this browser and device",
     "purrPopupSummary": "If you clear your cookies, your preference will be forgotten. As a California resident, you have additional rights under the California Consumer Privacy Act of 2018. While The New York Times Company does not “sell” personal information of its readers as the term “sell” is traditionally understood, “sell” under the CCPA is broadly defined. To learn more, review the text below.",
     "purrPopupButton": "DISMISS",
     "purrPopupScrollContent": 'ssa sed. Nec sagittis aliquam malesuada bibendum arcu. Nunc sed blandit libero volutpat sed cras ornare arcu. Metus vulputate eu scelerisque felis imperdiet proin. Elit eget gravida cum sociis natoque penatibus. Sodales ut eu sem integer. Vitae auctor eu augue ut lectus arcu bibendum at. Vulputate ut pharetra sit amet aliquam id diam. Eu tincidunt tortor aliquam nulla facilisi cras fermentum odio eu. Imperdiet dui accumsan sit amet nulla facilisi morbi. Laoreet non curabitur gravida arcu ac tortor dignissim. Magna fringilla urna porttitor rhoncus dolor purus. In nulla posuere sollicitudin aliquam. At elementum eu facilisis sed odio. Diam in arcu cursus euismod quis viverra. Viverra suspendisse potenti nullam ac tortor vitae purus. Felis donec et odio pellentesque diam volutpat. Lacus sed turpis tincidunt id aliquet risus feugiat in.Aliquam ut porttitor leo a diam sollicitudin tempor',
     "lang": 'zh-hant'
 };
 cbSectionName = "business";
 cbByline = "ANDREW POLLACK";</script><!-- Google Tag Manager --><script>(function(w,d,s,l,i){
     w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});
     var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
     j.async=true;j.src='../../../../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;
     f.parentNode.insertBefore(j,f);
 })(window,document,'script','dataLayer','GTM-KTDZV8V');</script><!-- End Google Tag Manager --><!-- chartbeat --><script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script><!-- /chartbeat --><body class="news"><main class="container-fluid main clearfix"><header class="row title-bar"><div class="nav-button default" id="menuBtn"><i class="icon-bars"></i></div><h1 class="logo"><a href="/"><svg role="img" aria-label="" width="90%" height="90%"><image width="100%" height="100%" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="/d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hant.svg" src="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hant%402x.png" alt="" border="0"></image></svg></a></h1><div class="nav-button default" id="gearBtn"><i class="icon-gear"></i></div><div class="popup gear-popup"><div class="tips-container"><div class="tips-border"></div><div class="tips-inner"></div></div><div class="popup-container"><div class="popup-body"><div class="setting-title">簡繁中文</div><div class="setting-option"><a href="../../index024e.html?changeLang=zh-hans">簡體 </a><a href="../../index27d8.html?changeLang=zh-hant" class="active">繁體</a></div><div class="setting-title">紐約時報 出版語言</div><ul class="menu-list"><li><a href="https://www.nytimes.com/">ENGLISH (英語)</a></li><li><a href="https://www.nytimes.com/es/">ESPAÑOL (西班牙語)</a></li></ul><div class="setting-title">字體大小</div><div class="setting-option"><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="small"> 小</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="normal" checked="checked"> 中</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="large"> 大</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="xlarge"> 超大</label></div></div></div></div></div></header><div class="top_banner_ad" id="topad" data-target="{&quot;pos&quot;:&quot;top&quot;,&quot;adv&quot;:&quot;&quot;}"></div><div class="article-area"><div class="setting-bar row"><div class="col-4 section-title"><h3>商業與經濟</h3></div><div class="col-8 setting-btns"><div class="row"><div class="col-6"><ul class="dual-btn"><li><a href="../../index.html"><span class="setting-btn-text">中文</span> <span class="setting-btn-text-mobile">中</span></a></li><li><a href="javascript:;" class="active"><span class="setting-btn-text">中英雙語</span> <span class="setting-btn-text-mobile">雙語</span></a></li><li><a href="#" target="_blank"><span class="setting-btn-text">英文 <i class="icon-share-square"></i> </span><span class="setting-btn-text-mobile">英</span></a></li></ul></div><div class="col-6 share-tools-top-container"><ul class="share-tools mobile-article"><li><a href="http://v.t.sina.com.cn/share/share.php?&amp;title=%E7%BE%8E%E5%9C%8B%E6%89%B9%E5%87%86%E4%B8%AD%E6%96%B9%E6%94%B6%E8%B3%BCDNA%E6%B8%AC%E5%BA%8F%E5%85%AC%E5%8F%B8&amp;url=https://cn.nytimes.com/business/20130101/c01genomics/zh-hant/" target="_blank"><i class="icon-weibo"></i></a></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20130101/c01genomics/zh-hant/" data-headline="%E7%BE%8E%E5%9C%8B%E6%89%B9%E5%87%86%E4%B8%AD%E6%96%B9%E6%94%B6%E8%B3%BCDNA%E6%B8%AC%E5%BA%8F%E5%85%AC%E5%8F%B8"> --><!-- <i class="icon-wechat"></i> --><!-- </a> --><!-- </li> --><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://cn.nytimes.com/business/20130101/c01genomics/zh-hant/" trage="_blank"><i class="icon-facebook"></i></a></li><li><a href="https://plus.google.com/share?url=https://cn.nytimes.com/business/20130101/c01genomics/zh-hant/" target="_blank"><i class="icon-google"></i></a></li><li><a href="https://twitter.com/share?text=%E7%BE%8E%E5%9C%8B%E6%89%B9%E5%87%86%E4%B8%AD%E6%96%B9%E6%94%B6%E8%B3%BCDNA%E6%B8%AC%E5%BA%8F%E5%85%AC%E5%8F%B8&amp;url=https://cn.nytimes.com/business/20130101/c01genomics/zh-hant/" target="_blank"><i class="icon-twitter"></i></a></li><li><div class="line-it-button" data-lang="zh_Hant" data-type="share-g" data-url="https://cn.nytimes.com/business/20130101/c01genomics/zh-hant/" style="display: none;"></div><script src="../../../../../../d.line-scdn.net/r/web/social-plugin/js/thirdparty/loader.min.js" async="async" defer="defer"></script></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20130101/c01genomics/zh-hant/" data-headline="%E7%BE%8E%E5%9C%8B%E6%89%B9%E5%87%86%E4%B8%AD%E6%96%B9%E6%94%B6%E8%B3%BCDNA%E6%B8%AC%E5%BA%8F%E5%85%AC%E5%8F%B8"> --><!-- <i class="icon-qrcode"></i> --><!-- </a> --><!-- </li> --></ul><div class="share-btn"><i class="icon-forward"></i></div></div></div></div></div><article class="article-content article-dual font-normal"><div class="article-header"><header><small></small><h1>美國批准中方收購DNA測序公司</h1><h1 class="en-title">U.S. Clears DNA Firm’s Acquisition by Chinese</h1></header><div class="byline-row"><div class="byline-box"><div class="byline"><address>ANDREW POLLACK</address><time pudate="2013-01-01 09:17:48" datetime="2013-01-01 09:17:48">2013年1月1日</time></div><div class="share-btn"><i class="icon-forward"></i></div></div></div></div><figure class="article-span-photo"><img src="../../../../../../static01.nyt.com/images/2012/12/31/business/jpGENOMICS/jpGENOMICS-jumbo.html" width="1024" height="613" alt="加利福尼亞州完整基因公司的DNA測序儀。該公司否認了有關併購的種種擔憂。"><figcaption><span>加利福尼亞州完整基因公司的DNA測序儀。該公司否認了有關併購的種種擔憂。</span> <cite>Ramin Rahimian</cite></figcaption></figure><div class="row"><section class="article-body"><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The federal government has given national security clearance to the controversial purchase of an American DNA sequencing company by a Chinese firm.</div></div><div class="col-lg-6"><div class="article-paragraph">一家中國企業對一家美國DNA測序公司充滿爭議的收購案，通過了美國聯邦政府的國家安全審查。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The Chinese firm, BGI-Shenzhen, said in a statement this weekend that its acquisition of Complete Genomics, based in Mountain View, Calif., had been cleared by the federal Committee on Foreign Investment in the United States, which reviews the national security implications of foreign takeovers of American companies. The deal still requires antitrust clearance by the Federal Trade Commission.</div></div><div class="col-lg-6"><div class="article-paragraph">中國企業深圳華大基因(BGI)在上周末的一份聲明中稱，它對於加州山景市的完整基因公司(Complete Genomics)的收購，已經得到了聯邦機構美國外國投資委員會(Committee on Foreign Investment in the United States)的批准。該委員會負責審查外國企業對美國企業的收購帶來的國家安全影響。不過這筆交易仍需通過美國聯邦貿易委員會(Federal Trade Commission)的反壟斷審查。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Some scientists, politicians and industry executives had said the takeover represented a threat to American competitiveness in DNA sequencing, a technology that is becoming crucial for the development of drugs, diagnostics and improved crops.</div></div><div class="col-lg-6"><div class="article-paragraph">一些科學家、政界人士和業界高管聲稱，這次收購將對美國在DNA測序領域的競爭力造成威脅。DNA測序技術在藥物、診斷學和農作物改良的研發過程中的作用日益重要。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The fact that the $117.6 million deal was controversial at all reflects a change in the genomics community.</div></div><div class="col-lg-6"><div class="article-paragraph">事實上，這筆價值1.176億美元（約合7.3億元人民幣）的交易產生爭議本身反映了基因界的一次轉變。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">A decade ago, the Human Genome Project, in which scientists from many nations helped unravel the genetic blueprint of mankind, was celebrated for its spirit of international cooperation. One of the participants in the project was BGI, which was then known as the Beijing Genomics Institute.</div></div><div class="col-lg-6"><div class="article-paragraph">10年前，由各國科學家共同參與繪製人類基因藍圖的人類基因組計劃(Human Genome Project)曾因其國際合作精神而受到讚揚。華大基因曾是該計劃的參與者之一，當時稱為北京基因組研究所。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">But with DNA sequencing now becoming a big business and linchpin of the biotechnology industry, international rivalries and nationalism are starting to move front and center in any acquisition.</div></div><div class="col-lg-6"><div class="article-paragraph">但是，隨着DNA測序現在成為了一門大生意，也成了生物技術產業的關鍵，國際競爭和民族主義開始在所有收購案中佔據核心位置。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Much of the alarm about the deal has been raised by Illumina, a San Diego company that is the market leader in sequencing machines. It has potentially the most to lose from the deal because BGI might buy fewer Illumina products and even become a competitor. Weeks after the BGI deal was announced, Illumina made its own belated bid for Complete Genomics, offering 15 cents a share more than BGI’s bid of $3.15. But Complete Genomics rebuffed Illumina, saying such a merger would never clear antitrust review.</div></div><div class="col-lg-6"><div class="article-paragraph">對這次交易的大部分警告來自Illumina公司。這家位於聖迭戈的公司是基因測序設備生產業的行業領先者。這家公司可能是這次交易的最大受害者，因為華大或許會減少Illumina產品的購買量，甚至成為一個競爭對手。在華大基因交易宣布數周后，Illumina也姍姍來遲地向完整基因公司提出了自己的收購要約，比華大基因開出的每股3.15美元要高出15美分。但完整基因公司斷然回絕了Illumina，稱這樣的收購將絕不可能通過反壟斷審查。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Illumina also hired a Washington lobbyist, the Glover Park Group, to stir up opposition to the deal in Congress. Representative Frank R. Wolf, Republican of Virginia, was the only member of Congress known to have publicly expressed concern.</div></div><div class="col-lg-6"><div class="article-paragraph">Illumina還僱傭了華盛頓遊說機構格洛弗帕克集團(Glover Park Group)，在國會中攪動起對這次交易的反對。弗吉尼亞州共和黨人、眾議員弗蘭克·R·沃爾夫(Frank R. Wolf)，是唯一公開對此表示出擔憂的一位議員。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">BGI and Complete Genomics point out that Illumina has long sold its sequencing machines — including a record-setting order of 128 high-end machines — to BGI without raising any security concerns. Sequencing machines have not been subject to export controls like aerospace equipment, lasers, sensors and other gear that can have clear military uses.</div></div><div class="col-lg-6"><div class="article-paragraph">華大基因和完整基因指出，Illumina曾長期向華大基因出售其基因測序儀器，其中一次售出了128部高端儀器創下了紀錄，而當時並未引起任何安全擔憂。基因測序儀器並不屬於美國出口限制商品。出口限制商品包括航空航天設備、激光設備、傳感器和其他可能具有明確軍事用途的儀器設備。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“Illumina has never previously considered its business with BGI as ‘sensitive’ in the least,” Ye Yin, the chief operating officer of BGI, said in a November letter to Complete Genomics that was made public in a regulatory filing. In the letter, Illumina was accused of “obvious hypocrisy.”</div></div><div class="col-lg-6"><div class="article-paragraph">華大基因首席運營官尹燁在11月發送給完整基因公司的一封信件中說，“Illumina此前從來沒有考慮過，它與華大的交易是‘敏感的’。”這封信件是在向監管部門提交的文件中披露的。信中指責Illumina，“明顯的虛偽”。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">BGI and Complete said that Illumina was trying to derail the agreement and acquire Complete Genomics itself in order to “eliminate its closest competitor, Complete.”</div></div><div class="col-lg-6"><div class="article-paragraph">華大基因和完整基因稱，Illumina試圖破壞協議，並自行收購完整基因，從而達到“消滅完整基因這個實力最接近的競爭對手”的目的。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">BGI is already one of the most prolific DNA sequencers in the world, but it buys the sequencing machines it uses from others, mainly Illumina.</div></div><div class="col-lg-6"><div class="article-paragraph">華大基因已經是世界上最多產的DNA測序機構之一，但它使用的測序儀器卻從別家購買，主要來自Illumina公司。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Illumina, joined by some American scientists, said it worried that if BGI gained access to Complete’s sequencing technology, the Chinese company might use low prices to undercut the American sequencing companies that now dominate the industry.</div></div><div class="col-lg-6"><div class="article-paragraph">Illumina以及一些美國科學家都表示，他們擔心如果華大基因能夠接觸到完整基因的測序技術，這家中國公司或許會以低價搶奪美國測序公司的生意，而這些公司目前主導着測序行業。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Some also said that with Complete Genomics providing an American base, BGI would have access to more DNA samples from Americans, helping it compile a huge database of genetic information that could be used to develop drugs and diagnostic tests. Some also worried about protection of the privacy of genetic information.</div></div><div class="col-lg-6"><div class="article-paragraph">也有一些人說，有了完整基因提供的美國數據庫，華大基因將能接觸到更多的來自美國人的DNA樣本，這將有助於華大基因編製巨大的遺傳信息數據庫，可用於開發新葯和診斷性醫療檢查。還有人擔心如此一來，難以保障遺傳信息的隱私。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“What’s to stop them from mining genomic data of American samples to some unknown nefarious end?” Elaine R. Mardis, co-director of the genome sequencing center at Washington University in St. Louis, said in an e-mail.</div></div><div class="col-lg-6"><div class="article-paragraph">“有什麼能阻止他們利用美國人樣本的基因組數據，去達到未知的邪惡目的？”聖路易斯華盛頓大學(Washington University in St. Louis)基因組序列中心聯合主任伊萊恩·R·瑪蒂斯(Elaine R. Mardis)在一封郵件中說道。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Dr. Mardis could not specify what kind of nefarious end she imagined. But opponents of the deal cited a <a title="Atlantic article on hacking presidential DNA." href="http://www.theatlantic.com/magazine/archive/2012/11/hacking-the-presidents-dna/309147/" rel="noopener noreferrer">November article in The Atlantic</a> saying that in the future, pathogens could be genetically engineered to attack particular individuals, including the president, based on their DNA sequences.</div></div><div class="col-lg-6"><div class="article-paragraph">瑪蒂斯不能具體說明她所能想像的邪惡目的會有哪些。但是這筆交易的反對者引用了《大西洋月刊》(The Atlantic)11月的一篇文章，說可以對病原體進行基因改造，根據個體的DNA序列，對人實施攻擊，潛在的受害者可能包括總統。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">BGI and Complete Genomics dismissed such concerns as preposterous.</div></div><div class="col-lg-6"><div class="article-paragraph">華大基因和完整基因對這些擔憂不以為然，說它們荒唐可笑。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“There is absolutely no basis for such a wild and speculative claim” about biological weapons, Clifford A. Reid, the chief executive of Complete Genomics, said in a regulatory filing.</div></div><div class="col-lg-6"><div class="article-paragraph">完整基因的首席執行官克利福德·A·里德(Clifford A. Reid)在一份監管文件中說道，有關生物武器的“瘋狂的、異想天開的說法毫無根據”。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">BGI already is doing sequencing of American DNA samples with partners including the Children’s Hospital of Philadelphia and the patient-advocacy group Autism Speaks. BGI said any sequencing intended for medical use of American patients would be done in the United States in accordance with American laws regarding clinical research and patient privacy.</div></div><div class="col-lg-6"><div class="article-paragraph">華大基因已經在和一些合作夥伴進行美國人類DNA樣本的測序，其中包括美國費城兒童醫院(Children's Hospital of Philadelphia)和病人權益倡導組織“自閉症之聲”(Autism Speaks)。華大基因說，任何針對美國患者的以醫療為目的的測序都會在美國進行，並遵循美國有關臨床研究和患者隱私的法律。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Some other executives at American sequencer manufacturers said they saw no cause for concern. “I can’t believe they can come up with a rational explanation of why this is a national security issue,” said Michael W. Hunkapiller, the chief executive of Pacific Biosystems.</div></div><div class="col-lg-6"><div class="article-paragraph">其他一些美國測序儀生產企業的高管們說，他們認為沒有必要擔心。“我不相信他們能合理地解釋，這為什麼會是一個國家安全問題，”太平洋生物系統公司(Pacific Biosystems)的首席執行官邁克爾·W·亨克皮勒(Michael W. Hunkapiller)說道。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Jonathan M. Rothberg, who runs the Ion Torrent sequencer division of Life Technologies, also said the acquisition “does not appear to raise national security issues.”</div></div><div class="col-lg-6"><div class="article-paragraph">生命技術公司(Life Technologies)離子激流(Ion Torrent)測序儀的負責人喬納森·M·羅思伯格(Jonathan M. Rothberg)也說，這次併購“看不出會引發任何國家安全問題”。 </div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Jay T. Flatley, the chief executive of Illumina, said there was a difference between selling sequencing machines and selling sequencing technology. He compared it selling someone a Coke and selling the formula to make Coca-Cola.</div></div><div class="col-lg-6"><div class="article-paragraph">Illumina公司的首席執行官傑伊·T·弗拉特利(Jay T. Flatley)說，出售測序儀器和出售測序技術不同。他說，這就好比賣給某人一瓶可樂，和出售生產可口可樂的配方之間的區別。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“Providing access to the fundamental technology is entirely different,” he said in an e-mail Friday. “It would allow funding from the Chinese government to move the technology forward at a pace that no U.S. company could match because we do not have access to such funding sources.”</div></div><div class="col-lg-6"><div class="article-paragraph">“提供基礎技術完全是另一回事，”他周五在一封郵件里說道，“這筆併購將使得來自中國政府的資金推動此類科技向前發展，這是美國公司無法企及的，因為我們沒有這樣的資金渠道。”</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Illumina has characterized BGI as an entity of the Chinese government. BGI denies that, saying it is a private company owned by its employees.</div></div><div class="col-lg-6"><div class="article-paragraph">Illumina將華大基因描述為中國政府的公司。華大基因予以否認，表示華大為私有企業，所有權屬於其員工。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Complete Genomics, while it makes it own sequencing machines, does not sell them to others. Rather, it offers sequencing as a service. Its customers have included the National Cancer Institute, Genentech and the Mayo Clinic.</div></div><div class="col-lg-6"><div class="article-paragraph">完整基因雖然製造自己的測序儀器，但並不出售。相反的，它提供測序的服務。它的客戶包括美國國家癌症研究所(National Cancer Institute)、基因泰克(Genentech)和梅約診所(Mayo Clinic)。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Mr. Hunkapiller of Pacific Biosciences said Complete’s technology is “very slow.”</div></div><div class="col-lg-6"><div class="article-paragraph">太平洋生物系統公司的亨克皮勒說，完整基因的技術“很慢”。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">He said of Illumina: “I can’t believe they are worried about Complete’s technology taking them out. That’s nuts.”</div></div><div class="col-lg-6"><div class="article-paragraph">關於Illumina，他說：“我不相信他們會擔心完整基因的技術把他們擠垮。那是瘋話。”</div></div></div></div><div class="article-body-aside col-lg-3"></div></div></section></div><div class="col-lg-12 row author-info-container"><footer class="author-info"><p>翻譯：曹莉、林蒙克</p></footer></div></article><div class="container article-footer"><div class="row"><div class="col-lg-12 dual-refer-cont"><div class="related-cont"><h4>相關報導</h4><ul class="refer-list"><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/health/20120910/c10genesecret/zh-hant/" title="基因測試結果，不能說的秘密"><div><h3 class="refer-list-headline">基因測試結果，不能說的秘密</h3><p class="refer-pubdate">2012年9月10日</p></div><img alt="基因測試結果，不能說的秘密" src="../../../../../../static01.nyt.com/images/2012/08/26/us/GENES-3/GENES-3-thumbLarge.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/health/20120820/c20cancerone/zh-hant/" title="醫學新突破：基因測序發現血癌元兇"><div><h3 class="refer-list-headline">醫學新突破：基因測序發現血癌元兇</h3><p class="refer-pubdate">2012年8月20日</p></div><img alt="醫學新突破：基因測序發現血癌元兇" src="../../../../../../static01.nyt.com/images/2012/07/08/health/gamble/gamble-thumbLarge.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/science/20120615/c15genome/zh-hant/" title="基因測序廉價化有助醫學進步"><div><h3 class="refer-list-headline">基因測序廉價化有助醫學進步</h3><p class="refer-pubdate">2012年6月15日</p></div></a></div></li></ul></div></div><div class="col-lg-12"><div class="related hot_article"><h5 class="related-title">最受歡迎</h5><ol class="related-articles"><li><a href="#https://cn.nytimes.com/usa/20220127/computer-chip-shortage-taiwan/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>戰棋推演報告稱台灣半導體工廠停產可能引發中美衝突</h4><img alt="戰棋推演報告稱台灣半導體工廠停產可能引發中美衝突" src="../../../../../../static01.nyt.com/images/2022/01/26/us/politics/26dc-wargames/merlin_177315390_5fcf8532-e370-4f81-8f99-45c6c83044f4-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/pakistan-united-states-china/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>「巴鐵」軍方為什麼想與中國保持距離？</h4><img alt="「巴鐵」軍方為什麼想與中國保持距離？" src="../../../../../../static01.nyt.com/images/2022/01/24/opinion/21Rafiq1/21Rafiq1-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220126/china-covid-19/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>中國追求「清零」將把國家置於災難之中</h4><img alt="中國追求「清零」將把國家置於災難之中" src="../../../../../../static01.nyt.com/images/2022/01/25/opinion/25emanuel/25emanuel-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/sports/20220127/peng-shuai-china-australian-open/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>澳網再現「彭帥在哪裡」：球員和觀賽者拒絕遺忘、為其發聲</h4><img alt="澳網再現「彭帥在哪裡」：球員和觀賽者拒絕遺忘、為其發聲" src="../../../../../../static01.nyt.com/images/2022/01/26/sports/26aus-china1/merlin_199503951_9c695f25-2b8e-41b4-9c97-bf91de7aa190-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220125/gang-chen-mit-china/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>「我們在殘害我們自己」：華裔教授陳剛案背後的憤怒與幻滅</h4><img alt="「我們在殘害我們自己」：華裔教授陳剛案背後的憤怒與幻滅" src="../../../../../../static01.nyt.com/images/2022/01/24/science/24CHEN-promo/24CHEN-promo-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/virtual-reality-simulation/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>我們可能活在模擬現實中，人類應該多擔憂這件事？</h4><img alt="我們可能活在模擬現實中，人類應該多擔憂這件事？" src="../../../../../../static01.nyt.com/images/2022/01/26/opinion/26manjoo-image/26manjoo-image-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/winter-olympics-china-beijing-xi-jinping/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>不再取悅世界：一屆展現習近平全面願景的冬奧會</h4><img alt="不再取悅世界：一屆展現習近平全面願景的冬奧會" src="../../../../../../static01.nyt.com/images/2022/01/13/world/00xi-olympics-30/00xi-olympics-30-thumbLarge.jpg"></article></a></li><li><a href="../../../../20220126/imf-world-economic-report/zh-hant/indexf61c.html?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>國際貨幣基金組織稱中美經濟放緩將拖累全球經濟</h4><img alt="國際貨幣基金組織稱中美經濟放緩將拖累全球經濟" src="../../../../../../static01.nyt.com/images/2022/01/25/multimedia/25global-econ-brf/25global-econ-brf-thumbLarge-v2.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/asia-pacific/20220126/north-korea-launches-missiles-kim/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>朝鮮突然頻繁試射導彈傳遞了什麼信息？</h4><img alt="朝鮮突然頻繁試射導彈傳遞了什麼信息？" src="../../../../../../static01.nyt.com/images/2022/01/21/world/00nkorea-gameplan-01/00nkorea-gameplan-01-thumbLarge.html"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/china-zero-covid-policy/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>多地封鎖引發沮喪與抱怨，中國「清零」政策還能走多遠？</h4><img alt="多地封鎖引發沮喪與抱怨，中國「清零」政策還能走多遠？" src="../../../../../../static01.nyt.com/images/2022/01/20/world/00virus-china-lockdown-01/00virus-china-lockdown-01-thumbLarge.html"></article></a></li></ol></div></div></div></div></div><footer class="row copy-footer">&copy; 2022 The World Economy Observer.<ul class="footerLinkList"><li class="footerLink"><a rel="nofollow" href="/ad/">广告</a></li><li class="footerLink"><a rel="nofollow" href="/about-us/">关于我们</a></li><li class="footerLink"><a rel="nofollow" href="/contact/">联系我们</a></li><li class="footerLink"><a rel="nofollow" href="/tos/">服务条款</a></li><li class="purr-content"></li></ul></footer><script src="../../../../../../d1f1eryiqyjs0r.cloudfront.net/js/libs/require619b.js?v=f1810d8"></script><script src="../../../../../../d1f1eryiqyjs0r.cloudfront.net/js/web/article.min619b.js?v=f1810d8"></script></main></body>
<!-- Mirrored from cn.nytimes.com/business/20130101/c01genomics/zh-hant/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:18:45 GMT -->
</html>